Creating new anticancer drugs is a billion dollar investment. By working with StemTek, pharmaceutical companies can save time and resources by outsourcing early drug discovery to our experienced R&D team.

Services

Creating new anticancer drugs is a billion dollar investment. By working with StemTek, pharmaceutical companies can save time and resources by outsourcing early drug discovery to our experienced R&D team.

Our value-added research services using Cell2Sphere™ technology offer rigorous analysis to profile compounds for their effect on cancer stem cell populations.
We specialize in early stage compound validation using 3D spheroid models to measure anti-cancer stem cell activity, from primary HTS screening to secondary validation, hit to lead assessment, lead optimization validation, fresh human tumor validation to in vivo efficacy studies.
 

Our Services

 

High Throughput Screening

Using Cell2Sphere™ technology.

Learn more

In vitro functional screening

In vitro efficacy compound profiling.

Learn more

In Vivo Functional Screening

Modified Xenograft models to assess tumor initiation.

Learn more

Human natural tumor screening

Increased physiological relevance for compound profiling.

Learn more

CUSTOM SERVICES
AD HOC RESEARCH SERVICES. YOUR PARTNER IN 3D DRUG SCREENING.

Our experts can advise on the right approach to help you plan and manage protocols in accordance with the aims of your study. Our ad-hoc department provides customized solutions to suit your R&D needs. We specialize on all aspects of the process from standardin vitro cell work, to in vivo efficacy testing.

Get in touch for more information.

 
 

CONTACT INFORMATION SERVICES
HOW CAN WE HELP YOU?

Do you have any questions or specific request for your research needs?
Please contact us:

 

 
Back to top